Letermovir

CAS 917389-32-3

Overview

Letermovir is an antiviral medication used for prophylaxis in adult transplant recipients at risk of cytomegalovirus (CMV) infection and disease

Anant Labs manufacture and furnish high quality Letermovir impurities for global markets. Our Letermovir EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Letermovir

Cat. No. ANTPRD7124Old No. ANT-LTM-000CAS 917389-32-3In Stock

Technical Data

New Cat. No.ANTPRD7124

Old Cat. No.ANT-LTM-000

CAS917389-32-3

Mol. FormulaC₂₉H₂₈F₄N₄O₄

Mol. Weight572.6 g/mol

IUPAC2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid

SMILESCOC1=C(C=C(C=C1)C(F)(F)F)N2[C@H](C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O

InChIInChI=1S/C29H28F4N4O4/c1-40-20-6-3-5-19(16-20)35-11-13-36(14-12-35)28-34-27-21(7-4-8-22(27)30)23(17-26(38)39)37(28)24-15-18(29(31,32)33)9-10-25(24)41-2/h3-10,15-16,23H,11-14,17H2,1-2H3,(H,38,39)/t23-/m0/s1

InChI KeyFWYSMLBETOMXAG-QHCPKHFHSA-N

Synonyms

(S)-2-(8-Fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acidLetermovir917389-32-3PrevymisAIC246AIC-246MK-8228AIC 2461H09Y5WO1F2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid